Graphene based Implant will Deepen the Understanding of Brain at Low Frequencies

Researchers in Barcelona have found a new grapheme based implant to map the brains activity below 0.1 Hz of frequency. The prototype created at Barcelona Microelectronics Institute will help in understanding the brains activity exponentially. For decades researchers were using electrode arrays to map the activity in the various parts of the brain. The electrode …

Intel and GE Healthcare’s New AI-based Solution Will Help Reduce Delay in Medical Diagnosis

Intel and GE Health’s, two of the  biggest players in the digital healthcare sector, have in a collaborative project shown promises to significantly reduce the time between imaging and medical diagnosis. The new technology will harness the Intel Distribution of OpenVINO Toolkit which runs on Intel’s x-ray systems to help prioritizing and optimizing patient care. …

Bristol-Myers Agrees on Acquisition of Celgene; Healthcare ETFs Remains the Key Focus

The healthcare industry has been continually witnessing a wave of strategic mergers and acquisitions, which could bring in major transformations in the spectrum of healthcare business. Post multiple series of consolidation between the pharmacy benefits managers and health insurers last year, biotech companies have been flourishing in the healthcare space as they have evolved as …

Governmental Policy Shift Along with Changing Landscape Threatens Chinese Drug maker’s Generic-based Business Model

Chinese drug maker’s stocks plunged by $46 billion in December 2018.  Chinese government is planning a shift in its drug pricing policy by undertaking bulk procurement of drugs as part of its new program. The move is significant as it will bring down prices of drugs as a major step towards universal and cheaper access …

Experimental Drug Promises a New Option for Type 2 Diabetes

An experimental drug may help curb blood sugar of patients with type2 diabetes without causing it to drop to extremely low levels. In a new study, a team of researchers has discovered that the compound–dubbed TTP399–improved the blood sugar control of patients, when it was added to metformin, the first-line medication for type 2 diabetes, …

Generation of Children May Live Shorter Lives than Their Parents due to Obesity

A generation of kids will possibly live shorter lives compared to their parents if nothing is done to cope with Wales’ obesity crisis, according to Dr. Frank Atherton, a chief medical officer. He predicted that obesity will soon takeover smoking as the biggest risk to public health and in 25 years’ time, it can become …

Report Reveals Outdated Commissioning Contracts are Failing UK Mental Health Services

A recent report, released by Johnson & Johnson’s Janssen Pharmaceutical Companies, uncovers that outdated contracts of mental health commissioning are failing cognitive health services in the UK. UK mental health services are falling behind its physical health services as the healthcare providers are relying on outdated commissioning process, according to the report. It also revealed …

New Report by EAT-Lancet Commission Suggests a Planetary Health Diet with 50% Reduced Intake of Sugar and Red Meat

The Lancet, one of the most prestigious medical journals in the world, has released a report which prescribes an ideal and healthy diet. The new dietary plan has taken into consideration all the factors of human body as well as meeting UN Conference on Climate Change goals for reducing carbon emissions. The report has recommended …

Lilly Gains Approval from NICE for its Verzenio Drug Which Acts as a CDK4/6 Inhibitor

Eli Lilly, an Indianapolis-based global pharmaceutical company has gained approval for its Verzenio drug used for treating breast cancer patients from UK’s National Institute of Health and Care Excellence (NICE). The approval has set stage for a 3 way competition in the CDK4/6 inhibitor drugs segment. The new drug is another addition to other such …

US and German Researchers have Developed a Blood Test to Detect Alzheimer’s Disease as Early as a Decade

A new blood test which tracks the level of neurofilament light chain, a protein in the blood may be adopted for the detection of Alzheimer’s and other neurodegenerative diseases a decade before first symptoms occur. The blood test developed as part of research study by collaboration of researchers from German Center for Neurodegenerative Diseases in …